BBCIC is the research arm of AMCP.
BBCIC is the Biologics & Biosimilars Collective Intelligence Consortium. BBCIC is a collaboration of managed care organizations, integrated delivery systems, pharmacy benefit management firms, research institutions, and pharmaceutical companies. The BBCIC is the only research network dedicated to post-marketing assessment of biosimilars. To date the following organizations have made financial and in-kind commitments: AbbVie, Aetna/CVS Health Clinical Trial Services, Amgen, HealthCore Inc./Elevance Health, Apobiologix, Arthritis Foundation, Boehringer Ingelheim Pharmaceuticals, Inc, Express Scripts, Inc., Group Health Cooperative/Kaiser Permanente of Washington Research Institute, Harvard Pilgrim Health Care, HealthPartners, Henry Ford Health System, IQVIA, Momenta Pharmaceuticals, Inc., Merck, Optum, Patient Advocate Foundation, PearlDiver Technologies™, Pfizer, Sandoz and the Hematology Oncology Pharmacy Association.